Relationship between Circulating miR-155 and Inflammatory Factors in Gastric Carcinoma and Its Significance in the Diagnosis of Gastric Cancer
Abstract: Objective: To investigate the correlation between miR-155 and inflammatory factors in gastric cancer and its significance in the diagnosis of gastric cancer. Methods: The relative expression of miR-155 in serum of patients with gastric cancer detected by qRT-PCR; ELISA analysis the secre-tion of inflammatory cytokines including IL-1β, IL-6, IL-8 in gastric cancer cell line SGC-7901, si-lencing miR-155 by small molecule interference. Results: The level of miR-155 in serum of pa-tients with gastric cancer was significantly higher than that in healthy people, and ROC curve analysis showed that the serum miR-155 had a better diagnostic value in the diagnosis of gastric cancer. In addition, inflammatory cytokines IL-6, IL-8 levels were positively correlated with serum miR-155 level in serum of patients with gastric cancer gastric cancer; silencing of miR-155 inhibited inflammatory factor IL-1beta, IL-6, IL-8 secretion in gastric cancer cells. Conclusion: The level of miR-155 in serum is of significance in the diagnosis of gastric cancer, and it can regulate the secretion of inflammatory factors IL-1beta, IL-6 and IL-8 in gastric cancer.
文章引用: 洪宏海 , 陈金桃 , 林丽英 (2017) 循环miR-155与胃癌炎症因子相关性分析及在胃癌诊断中意义研究。 世界肿瘤研究， 7， 69-74. doi: 10.12677/WJCR.2017.73011
Zhang, T., et al. (2013) Overexpression of Methionine Adenosyltransferase II Alpha (MAT2A) in Gastric Cancer and Induction of Cell Cycle Arrest and Apoptosis in SGC-7901 Cells by shRNA-Mediated Silencing of MAT2A Gene. Acta Histochemica, 115, 48-55.
Nathan, C. and Ding, A. (2010) Nonresolving Inflammation. Cell, 140, 871-882.
Narita, Y. and Muro, K. (2017) Challenges in Molecular Targeted Therapy for Gastric Cancer: Considerations for Efficacy and Safety. Expert Opinion on Drug Safety, 16, 319-327.
Guo, H., et al. (2010) Mammalian microRNAs Predominantly Act to Decrease Target mRNA Levels. Nature, 466, 835-840.
Baulande, S., Criqui, A. and Duthieuw, M. (2014) Circulating miRNAs as a New Class of Biomedical Markers. Med Sci (Paris), 30, 289-296.
Hessam, S., et al. (2017) Expression of miRNA-155, miRNA-223, miR-NA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa. Inflammation, 40, 464-472.
Song, J. and Lee, J.E. (2015) miR-155 Is Involved in Alzheimer’s Disease by Regulating T Lymphocyte Function. Frontiers in Aging Neuroscience, 7, 61.
Chung, H.W. and Lim, J.B. (2014) Role of the Tumor Microenvironment in the Pathogenesis of Gastric Carcinoma. World Journal of Gastroenterology, 20, 1667-1680.
Harada, K., et al. (2017) Global Chemotherapy Development for Gastric Cancer. Gastric Cancer, 20, 92-101.
Shaker, O., et al. (2015) Role of microRNAs-29b-2, -155, -197 and -205 as Diagnostic Biomarkers in Serum of Breast Cancer Females. Gene, 560, 77-82.
Strand, M.S., Lockhart, A.C. and Fields, R.C. (2017) Genetics of Gastric Cancer. Surgical Clinics of North America, 97, 345-370.
Fettelschoss, A., et al. (2011) Inflammasome Activation and IL-1beta Target IL-1alpha for Secretion as Opposed to Surface Expression. Proceedings of the National Academy of Sciences of the USA, 108, 18055-18060.
 Lukaszewicz-Zajac, M., Mroczko, B. and Szmitkowski, M. (2010) The Role of Interleukin-6 and C-Reactive Protein in Gastric Cancer. Polski Merkuriusz Lekarski, 29, 382-386.